Landmark trials in endocrine adjuvant therapy for breast carcinoma

William Gradishar*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


The review summarizes the outcomes of several landmark trials involving aromatase inhibitors that helped formulate current therapeutic approaches recommended by the American Society of Clinical Oncology for breast carcinoma treatment.

Original languageEnglish (US)
Pages (from-to)975-981
Number of pages7
Issue number5
StatePublished - Mar 1 2006


  • Aromatase inhibitors
  • Breast carcinoma
  • Clinical trials
  • Endocrine adjuvant therapy
  • Tamoxifen

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Landmark trials in endocrine adjuvant therapy for breast carcinoma'. Together they form a unique fingerprint.

Cite this